Notes in molecular

To Subscribe, use this Key

Status	Last Update	Fields
Published	12/13/2024	{{c1::Desmoplastic small round cell tumors}} are associated with genetic alterations involving:1. {{c2::EWSR1}}-{{c2::WT1}} fusions [t({{c3::11;2…
Published	12/13/2024	{{c1::Infantile fibrosarcoma}} are associated with genetic alterations involving:1. {{c2::ETV6}}-{{c2::NTRK3}} fusions [t({{c3::12; 15}})] (90%).
Published	12/13/2024	{{c1::CIC-rearranged sarcoma}} are associated with genetic alterations involving:1. {{c2::CIC}}-{{c2::DUX4}} fusions [t({{c3::4; 19}})] (>90%)…
Published	12/13/2024	{{c1::Alveolar rhabdomyosarcomas}} are associated with genetic alterations involving:1. {{c2::PAX3}}-{{c2::FOXO1}} fusions [t({{c3::2; 13}})] (60…
Published	12/13/2024	{{c1::Synovial sarcomas}} are associated with genetic alterations involving:1. {{c2::SS18}}-{{c2::SSX1}} fusions [t({{c3::X; 18}})] (60%; {{c4::m…
Published	12/13/2024	{{c1::Solitary fibrous tumors}} are associated with genetic alterations involving:1. {{c2::NAB2}}-{{c2::STAT6}} fusions [{{c3::inv(12)}}] (90%).
Published	12/13/2024	{{c1::Nodular fascitis}} and {{c4::aneurysmal bone cysts}} are associated with genetic alterations involving:1. {{c2::MYH9}}-{{c2::USP6}} fu…
Published	12/13/2024	{{c1::Angiomatous fibrous histiocytoma}} is associated with genetic alterations involving:1. {{c2::EWSR1}}-{{c2::CREB1}} fusions [t({{c3::2; 22}}…
Published	12/13/2024	{{c1::NUT carcinoma}} is associated with genetic alterations involving:1. {{c2::BRD4}}-{{c2::NUTM1}} fusions [t({{c3::15; 19}})] (80%).2. {{c4::B…
Published	12/13/2024	{{c1::Dermatofibrosarcoma protuberans}} is associated with genetic alterations involving:1. {{c2::COL1A1}}-{{c2::PDGFB}} fusions [t({{c3::17; 22}…
Published	12/13/2024	{{c1::Clear cell sarcoma}} (melanoma of soft parts) is associated with genetic alterations involving:1. {{c2::EWSR1}}-{{c2::ATF1}} fusions [t({{c…
Published	12/13/2024	{{c1::Clear cell sarcoma}} of {{c6::GI tract}} is associated with genetic alterations involving:1. {{c2::EWSR1}}-{{c2::ATF1}} fusions […
Published	12/13/2024	{{c1::Ewing sarcoma}} is associated with genetic alterations involving:1. {{c2::EWSR1}}-{{c2::FLI1}} fusions [t({{c3::11; 22}})] (90%).2. {{c4::E…
Published	12/13/2024	{{c1::Mesenchymal chondrosarcoma}} is associated with genetic alterations involving:1. {{c2::HEY1}}-{{c2::NCOA2}} fusions [t({{c3::8; 8}})] (~80%…
Published	12/13/2024	{{c1::Myxoid}} and {{c1::round cell lipo}}-sarcomas are associated with genetic alterations involving:1. {{c2::FUS}}-{{c2::DDIT3}} fusions [t({{c…
Published	12/13/2024	The most common cause of death from cardiovascular disease is {{c1::coronary artery disease}}.
Published	12/13/2024	{{c1::Gastrointestinal stromal tumors}} are associated with molecular alterations involving:1. {{c3::KIT mutations}} (~{{c2::80}}% cases).2. {{c4…
Published	12/13/2024	{{c3::Orbital}} melanomas are associated with molecular alterations involving {{c1::GNAQ}} or {{c1::GNA11}} mutations in ~{{c…
Published	12/13/2024	{{c1::Larotrectinib}} is a targeted therapy for molecular alterations involving {{c2::ETV6-NTRK3 translocations [t(12;15)]}}.
Published	12/13/2024	The {{c1::ETV6-NTRK3 translocation [t(12; 15)]}} molecular alteration is seen in:1. {{c2::Infantile fibrosarcoma}}.2. {{c4::Salivary secreto…
Published	12/13/2024	{{c1::Gastrointestinal stromal tumors}} with molecular alteration involving {{c2::KIT}} and {{c2::PDGFRA}} mutations can be t…
Published	12/13/2024	Renal {{c1::medullary carcinomas}} is associated with molecular alterations involving {{c2::SMARCB1 loss}} (~{{c3::90}}% cases) an…
Published	12/13/2024	Increased expression of {{c3::carbonic anhydrase IX (CAIX)}} is a consquence of genetic {{c2::VHL inactivation}} and occurs diffus…
Published	12/13/2024	Inflammatory myofibroblastic tumors are associated with molecular alterations most commonly involving {{c1::ALK rearrangements with a variety of …
Status	Last Update	Fields